On one hand, the angiogenic factor vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of EMS 48, and selective COX-2 inhibitors suppress the expression of VEGF in endometrial grafts initially 127 and in tumor researches 139. This evidence concerns the gene VEGFA and neoplasm.